Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06010277
What this trial is testing

Folinic Acid for Prevention of Pemetrexed-induced Toxicity

Who this might be right for
NSCLCMesotheliomaThymoma
Amphia Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02187783
What this trial is testing

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

Who this might be right for
Tumors With CDK4/6 Pathway Activation
Novartis Pharmaceuticals 106
Testing effectiveness (Phase 2)Ended earlyNCT00604461
What this trial is testing

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
H. Lee Moffitt Cancer Center and Research Institute 13
Early research (Phase 1)Study completedNCT00165555
What this trial is testing

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 70
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Not applicableUnknownNCT06410625
What this trial is testing

Evaluation of Response by FLT PET in Mesothelioma

Who this might be right for
Pleural MesotheliomaTreatment ResponseChemotherapy Effect
Ankara University 25
Testing effectiveness (Phase 2)Study completedNCT02139904
What this trial is testing

Vinorelbine in Mesothelioma

Who this might be right for
Mesothelioma
Wales Cancer Trials Unit 154
Not applicableActive Not RecruitingNCT04450043
What this trial is testing

The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance

Who this might be right for
Non Small Cell Lung CancerSmall-cell Lung CancerMesothelioma+1 more
Massachusetts General Hospital 21
Not applicableWithdrawnNCT04429204
What this trial is testing

Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma

Who this might be right for
Mesothelioma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Early research (Phase 1)Study completedNCT04375267
What this trial is testing

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

Who this might be right for
Clinical Trial, Phase INeuroendocrine TumorsThymoma+1 more
Vastra Gotaland Region 18
Early research (Phase 1)Study completedNCT02959463
What this trial is testing

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center 25
Not applicableUnknownNCT06491784
What this trial is testing

EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility

Who this might be right for
Mesothelioma
NHS Greater Glasgow and Clyde 40
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Not applicableStudy completedNCT03537833
What this trial is testing

Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

Who this might be right for
Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
CHU de Reims 172
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Early research (Phase 1)WithdrawnNCT04201145
What this trial is testing

Pembrolizumab + Defactinib In Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Raphael Bueno, MD
Next Page